World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
13945
World Ranking
9225
National Ranking
4083

Binfeng Lu publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Binfeng Lu sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 139 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Binfeng Lu D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Binfeng Lu sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Binfeng Lu is affiliated with the University of Pittsburgh in the United States. Their research spans multiple fields primarily focused on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Subfields of note include immunology, oncology, molecular biology, cancer research, and mechanical engineering.

The scientist's research topics emphasize various aspects of cancer immunotherapy, immune cell function, and gene delivery methods. Key topics include:

  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Single-cell and spatial transcriptomics
  • RNA Interference and Gene Delivery
  • IL-33, ST2, and ILC Pathways

Several recent papers exemplify the scope and focus of their work, including:

  • Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy (2022), published in Nature Nanotechnology
  • Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions (2020), published in Scientific Reports
  • Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways (2022), published in Molecular Cancer
  • The IL-1 family in tumorigenesis and antitumor immunity (2022), published in Seminars in Cancer Biology
  • Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy (2020), published in Cancer Immunology Research

Frequent co-authors collaborating with Binfeng Lu include:

  • Runzi Sun
  • Song Li
  • Jingting Jiang
  • Xinghua Lu
  • Lujia Chen

Their publications appear often in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science Advances
  • Frontiers in Cell and Developmental Biology
  • Journal for ImmunoTherapy of Cancer
  • Cancer Immunology Research

Best Publications

  • Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis

    Dengke K. Ma;Mi Hyeon Jang;Junjie U. Guo;Yasuji Kitabatake

  • Autophagy Reduces Acute Ethanol-Induced Hepatotoxicity and Steatosis in Mice

    Wen–Xing Ding;Min Li;Xiaoyun Chen;Hong–Min Ni;Hong–Min Ni

  • Early Growth Response Gene 1–mediated Apoptosis Is Essential for Transforming Growth Factor β1–induced Pulmonary Fibrosis

    Chun Geun Lee;Soo Jung Cho;Min Jong Kang;Svetlana P. Chapoval

  • TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.

    Xin Gao;Yibei Zhu;Yibei Zhu;Gang Li;Haitao Huang

  • CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

    Moa Fransson;Elena Piras;Joachim Burman;Berith Nilsson

  • Autophagy Is Induced in CD4+ T Cells and Important for the Growth Factor-Withdrawal Cell Death

    Changyou Li;Elizabeth Capan;Yani Zhao;Jianping Zhao

  • Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

    Zong Sheng Guo;Binfeng Lu;Zongbi Guo;Esther Giehl

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor

    Liangrong Shi;Lujun Chen;Changping Wu;Yibei Zhu

  • Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells

    Xin Gao;Xuefeng Wang;Qianting Yang;Xin Zhao

  • TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

    Wenwen Du;Min Yang;Abbey Turner;Chunling Xu

  • Immune Modulation by Volatile Anesthetics

    Lindsay M. Stollings;Li-Jie Jia;Pei Tang;Huanyu Dou

  • Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.

    Guangbo Zhang;Jianquan Hou;Jinfang Shi;Gehua Yu

  • Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery

    J R Kovacs;C Li;Q Yang;G Li;G Li

  • IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells

    Qianting Yang;Gang Li;Gang Li;Yibei Zhu;Yibei Zhu;Lin Liu

  • An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma

    Yichen Tang;Xuejun Xu;Shixiang Guo;Chaobin Zhang

  • GADD45γ Mediates the Activation of the p38 and JNK MAP Kinase Pathways and Cytokine Production in Effector TH1 Cells

    Binfeng Lu;Hong Yu;Chi Wing Chow;Baiyong Li

  • Cytokine-induced killer cells promote antitumor immunity.

    Jingting Jiang;Changping Wu;Binfeng Lu

  • T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses

    Yibei Zhu;Songguang Ju;Elizabeth Chen;Shao Dai

  • Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion

    Robert L. Ferris;Binfeng Lu;Lawrence P. Kane

Frequent Co-Authors

Jingting Jiang
Jingting Jiang Soochow University
Xueguang Zhang
Xueguang Zhang Soochow University
Richard A. Flavell
Richard A. Flavell Yale University
Song Li
Song Li University of Pittsburgh
Evelina Gatti
Evelina Gatti Aix-Marseille University
Shazib Pervaiz
Shazib Pervaiz National University of Singapore
Sergio Lavandero
Sergio Lavandero University of Chile
Leonidas C. Platanias
Leonidas C. Platanias Northwestern University
Hsing Jien Kung
Hsing Jien Kung Taipei Medical University
Beth Levine
Beth Levine The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to a variety of online degrees and career paths in healthcare and science. For students eager to start working sooner, pursuing a fast track nutrition degree is one way to quickly gain industry-relevant skills. Those interested in leadership may consider an affordable online mba healthcare management program to enhance their business and managerial expertise within health services.

The medical coding field is another promising option for biology and biochemistry graduates. It's important to understand the distinctions between certifications, such as cpc vs ccs, to choose the qualification that best aligns with your career interests and expected salary outcomes. If you're considering this pathway, you may wonder how long does it take to become a medical coder. Fortunately, medical coding programs can often be completed within a year, providing a quick entry into the healthcare workforce.

Best Scientists Citing Binfeng Lu

Trending Scientists

Recently Published Articles